The FDA has accepted GSK's BLA for a 5-in-1 meningococcal vaccine candidate, which promises streamlined immunization and a potential reduction in invasive meningococcal disease (IMD).

Hospitals using CDC prevention strategies had different incidences of hospital-associated Clostridioides difficile infection compared to those that didn't, but the reasons are not necessarily the strategies themselves.

Ramon Zegpi Lagos, DVM, PhD, discusses H5N1 (avian flu), risks, transmission dynamics, preventive measures, and ongoing research at The Ohio State University.

Infection Control Today's Product Locator is a monthly column that highlights some of the latest advanced technology in infection prevention.

A JAMA study exposes the US healthcare system's staggering waste expenditure underlining challenges in managing diverse waste types and stringent regulations' compliance. What solutions are there?

Read on about how, as hospitals grapple with the costly burden of healthcare-associated infections (HAIs), artificial intelligence (AI) emerges as a game-changer in revolutionizing infection prevention strategies.

The role of infection preventionists (IPs) has evolved significantly over 75 years, from early surveillance of nosocomial infections to becoming data-driven experts navigating pandemics like COVID-19.

Merck's V116, a 21-valent pneumococcal vaccine, exhibits strong immunogenicity and coverage in diverse adult populations. Real-world data reveal its potential to combat pneumococcal diseases effectively.

Carole W. Kamangu, MPH, RN, CIC, shares her inspiring journey from the Democratic Republic of Congo to health care leadership in the US today. (This is the French translation of the interview with Carole W. Kamangu.)

Carole W. Kamangu, MPH, RN, CIC, shares her inspiring journey from the Democratic Republic of Congo to health care leadership in the US today.

A well-organized SPD not only keeps the surgical schedule on track but also minimizes backlogs and ensures the timely removal of bioburden—a crucial factor in preventing infections. To achieve this level of efficiency, attention to 5 pivotal areas is essential.

Bug of the Month helps educate readers about existing and emerging pathogens of clinical importance in health care facilities today.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending April 7, 2024.

Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.

The fight against poliovirus continues with renewed urgency as recent surveillance data reveals both progress and persistent challenges. In a critical update, infection prevention personnel are presented with key insights into the ongoing battle against this scourge.

Recent research in the American Journal of Infection Control reveals gaps in routine hospital disinfection, highlighting the need for UV-C audits. Learn how to validate UV-C dosages effectively and conduct successful audits.

Learn about the FDA's approval of Zevtera (ceftobiprole medocaril sodium) for Staphylococcus aureus infections in adults and pediatric patients, including common side effects and precautions.

Discover Alaska's borealpox virus, formerly Alaskapox, now named for its ecosystem origins. Learn about this orthopoxvirus affecting humans and small mammals, with prevention insights.

Discover the considerations behind CSL Seqirus' shift to trivalent influenza vaccines, removing B/Yamagata strain. Gregg Sylvester, MD, MPH, explains the impact on effectiveness and steps for a seamless transition in health care facilities.

Important Recall Notice: AvKARE recalls Atovaquone Oral Suspension due to potential Bacillus cereus contamination. Learn about risks, recommendations, and how to proceed if you have this product.

Puerto Rico declared a dengue public health emergency with 549 cases this year, up from 1293 in 2023. What should visitors and residents know to protect themselves?

Media in the US presents AI as both beneficial and risky. Positive coverage shows AI's potential through virtual assistants like Siri, while cautionary tales warn of misuse like misinformation and deepfakes. How does all this work in health care?

Stay informed on the growing threat of Candida auris with expert insights on its multidrug-resistance, clinical manifestations, and effective prevention strategies for health care settings.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending March 31, 2024.

Explore Agilent Technologies' role in advancing infectious disease research through cutting-edge solutions, from in vitro transcribed RNA vaccine testing to biofilm evaluation.